- Home
- Products
- Customized FluoroAb™
- CD4
- Keliximab-Cy3
Keliximab-Cy3 (CAT#: ADC-FL-662)
- TARGET
- ANTIBODY
- DYE
- Name
- CD4
- Alternative Names
- CD4; CD4 molecule; CD4 antigen (p55) , T cell surface glycoprotein CD4; T-cell surface glycoprotein CD4; CD4 receptor; CD4 antigen (p55); T-cell surface antigen T4/Leu-3; CD4mut;
- Overview
- This gene encodes a membrane glycoprotein of T lymphocytes that interacts with major histocompatibility complex class II antigenes and is also a receptor for the human immunodeficiency virus. This gene is expressed not only in T lymphocytes, but also in B cells, macrophages, and granulocytes. It is also expressed in specific regions of the brain. The protein functions to initiate or augment the early phase of T-cell activation, and may function as an important mediator of indirect neuronal damage in infectious and immune-mediated diseases of the central nervous system. Multiple alternatively spliced transcript variants encoding different isoforms have been identified in this gene.
- Overview
- Chimeric Anti-CD4 IgG17-lambda antibody, Keliximab
- Generic name
- Keliximab
- Species Reactivity
- Human
- Name
- Cy3
- Color
- Orange
- Excitation⁄Emission (nm)
- 554/568
- Detection method
- Fluorescent
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-FL-662. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-882 | Anti-CD4 (Clenoliximab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
| ADC-W-883 | Anti-CD4 (Clenoliximab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
| ADC-W-884 | Anti-CD4 (Cedelizumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-889 | Anti-CD4 (Cedelizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
| ADC-W-881 | Anti-CD4 (Clenoliximab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-C. albicans Hsp90 MAb (Clone 1)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14598)
- Teplizumab-Fluoresein (CAT#: ADC-FL-556)
- Anti-APP MAb (Clone 8)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS119)
- Anti-CD5 MAb (Clone 5)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS5808)
- Anti-IGF1R MAb (Clone 2)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14453)
- Anti-CTLA4 MAb (Clone 14)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS5860)
- Anti-ERBB2 MAb (Clone 15)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14210)
- Anti-CD79B MAb (Clone 3)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS240)
- Anti-FUT4 MAb (Clone 1)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS5215)
- Anti-CD44 MAb (Clone 3)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS3592)
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
